Through the use of virtual high-throughput screening and other computer-aided drug discovery methods, researchers at Yale University have investigated drugs to treat HIV, cancer and other diseases. Now, the group has teamed up with Swiss biopharma Debiopharm to discover and develop inhibitors for autoimmune and inflammatory diseases … more

A team of Yale School of Medicine researchers has developed a measure for hospitals based on the complications following their patients’ hip and knee replacements … more

Yale University researchers have determined how a scarce molecule produced by marine bacteria can kill cancer cells, paving the way for the development of new, low-dose chemotherapies … more

Biomedical engineers at Yale University have developed a new model for studying how an organ’s inflammation is affected by nearby nonliving connective tissue, such as the collagen in the amniotic membrane, tendons, and cartilage … more

Yale New Haven Health will become the first health system in New England to join eHealth Exchange, a national network that allows hospitals and other healthcare organizations to securely share information about patients they’re treating … more




5/14 9:00 am – 4:00 pm in New Haven

Diabetes Symposium: “Innovative Approaches to Diabetes Research and Therapies”  … more


5/22 9:00 am – 4:00 pm in New Haven
Biotech Entrepreneur Bootcamp – daylong workshop … more